Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Current Opinion in Oncology|January 11, 2022
Recent advances in radiosensitivity determinants in melanomaMohammad Krayem, Ghanem E Ghanem, Dirk Van Gestel
Technical Innovations & Patient Support in Radiation Oncology|April 15, 2022
Qualitative evaluation of the role of RTTs IGRT specialists and their influence on treatment deliveryFilipa Sousa, Monica Somoano, Younes Jourani, et al.
Frontiers in Oncology|April 1, 2020
Radiotherapy Quality Assurance for Head and Neck Squamous Cell CarcinomaDirk Van Gestel, Tatiana Dragan, Vincent Grégoire, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 23, 2018
Dose-response in choroidal melanomaAlex De Caluwé, Karolien Termote, Dirk Van Gestel, et al.
Radiation Oncology (London, England)|October 14, 2016
Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapyFien Hoefkens, Charlotte Dehandschutter, Johan Somville, et al.
Cancer Medicine|October 1, 2019
Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2Christelle Bouchart, Anne-Laure Trépant, Matthieu Hein, et al.
Translational Lung Cancer Research|May 20, 2021
Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open questionPaul Van Houtte, Luigi Moretti, Florian Charlier, et al.
Frontiers in Oncology|April 5, 2021
Impact of the COVID-19 Pandemic on Patients and Staff in Radiation Oncology Departments in Belgium: A National SurveyAude Vaandering, Selma Ben Mustapha, Maarten Lambrecht, et al.
Frontiers in Immunology|April 3, 2023
The current understanding of the immune landscape relative to radiotherapy across tumor typesChrysanthi Iliadi, Laurine Verset, Christelle Bouchart, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 18, 2020
Brachytherapy in Belgium in 2018. A national survey of the brachytherapy study group of the Belgian SocieTy for Radiotherapy and Oncology (BeSTRO)Carl Salembier, Olivier De Hertogh, Jean-François Daisne, et al.
Pageof 8